1.44BMarket Cap-7630P/E (TTM)
22.690High21.750Low543.98KVolume22.150Open22.160Pre Close12.11MTurnover1.07%Turnover RatioLossP/E (Static)64.41MShares24.37752wk High3.87P/B1.13BFloat Cap4.22052wk Low--Dividend TTM50.86MShs Float52.380Historical High--Div YieldTTM4.24%Amplitude4.220Historical Low22.264Avg Price1Lot Size
Nurix Therapeutics Stock Forum
as this guy 👇
$Taysha Gene Therapies (TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals (TFFP.US)$ 14% Clinical programs update
$Jaguar Health (JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin (SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems (DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences (SLS.US)$ 0% Closes $20M offering & private placement
$Immunic (IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics (NRIX.US)$ 0...
Nurix said patients currently enrolled in the trial who are deriving clinical benefit are allowed to continue receiving the current drug product. The screening and enrollment of new patients has been paused.
The company sai...
No comment yet